The Diphtheria Treatment Market is expected to reach $ 5 billion by the end of 2023, this market is
projected to be growing at a CAGR of ~ 3.2 % during 2017-2023.
Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing
severe sore throat and fever leading to narrowing of the air passages and barking cough. Diphtheria
may also affect the skin, eyes, or genitals and may cause myocarditis, bleeding and kidney
problems.
The Global Diphtheria Treatment Market is growing at a slow rate due to high effectiveness and
efficiency of the vaccine, falling profitability of vaccine manufacture, side effects associated with
vaccines such as type A immune reaction and allergies, variability in the efficacy of vaccines.
Financial restraints such as falling returns on investment and the resultant exit of a number of
players from vaccine manufacture will affect the future growth of vaccines.
Considering all these factors the market for diphtheria treatment is expected to reach $ 5 billion by
the end of 2023, this market is projected to be growing at a CAGR of ~ 3.2 % during 2017-2023.
Key players of Global Diphtheria treatment Market:
Key players profiled in the report are Taj Pharmaceuticals Limited, Bharat Pharmaceuticals, GSK,
Sanofi-Pasteur, Merck & Co., Shanghai Institute of Biological Products, Wuhan Institute of Biological
Products, Serum Institute of India, Wyeth, Chiron Pharmaceutical Pvt Ltd. and others.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/3828 .
The Global Diphtheria Treatment Market is segmented on the basis of product type and end
users. Based on product type, the market has been segmented as Tetanus Immune Globulin
(TIG), Tetanus Toxoid (TT), Tetanus-diphtheria (Td), Diphtheria Toxoid and Pertussis
(DTaP). Based on the treatment, the market has been segmented as antitoxin, antibiotics,
macrolides and others. Based on the end users, the market has been segmented as
hospitals and clinics, academics and research, and others.
Regional analysis
US accounts for the maximum market share due to favorable reimbursement scenario and
greater expenditure on healthcare. The faster market uptake of new technology in the US is
also an important driver of the market for global diphtheria treatment. Europe is the second
largest market due to large disposable income and rising awareness. Asia Pacific region is
the fastest region because of large unmet needs which is led by China and India. The Middle
East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor
regions of Africa are expected to be a laggard due to poor economic and political conditions
and poor healthcare penetration. Asia Pacific region is expected to overtake the developed
regions in the near future.
Major TOC for Diphtheria Treatment Market:
1. Report Prologue